Skip to content

Study on the protective effect of dexmedetomidine of different modes of administration on the myocardium of rheumatic heart disease with valve replacement surgery

Study on the protective effect of dexmedetomidine of different modes of administration on the myocardium of rheumatic heart disease with valve replacement surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011955
Enrollment
Unknown
Registered
2017-07-12
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic heart disease

Interventions

Precondition group:Dexmedetomidine precondition
Whole pump group:Dexmedetmidine whole pump group
Control group:Normal saline

Sponsors

First Affiliated Hospital of Zunyi Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old; 2. expected operation time> 2h, <7h; 3. ASA grade I to III grades, NYHN grade I to III grades; 4. acquired patient or family consent and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. myocardial infarction occurred within 1 month; 2. history of cardiac surgery; 3. preoperative rheumatoid activity; 4. heparin resistance, drug allergy history; 5. preoperative severe anemia; 6. preoperative stop anticoagulants 4 times) and the difficulty of stopping; 11. patients or their families refused to participate, did not sign informed consent; 12. patients or family members out of the way, data loss, missing.

Design outcomes

Primary

MeasureTime frame
Troponin I;Creatine kinase isoenzyme;Brain natriuretic peptide;Malondialdehyde;Interleukin 8;Interleukin 10;Tumor necrosis factor alpha;Blood sugar;

Countries

China

Contacts

Public ContactHaiying Wang

First Affiliated Hospital of Zunyi Medical College

Wanghaiting-8901@163.com+86 18685268901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026